M.N.L. Nalam

1.7k total citations
21 papers, 1.3k citations indexed

About

M.N.L. Nalam is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, M.N.L. Nalam has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 18 papers in Virology and 8 papers in Molecular Biology. Recurrent topics in M.N.L. Nalam's work include HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (3 papers). M.N.L. Nalam is often cited by papers focused on HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (3 papers). M.N.L. Nalam collaborates with scholars based in United States and Türkiye. M.N.L. Nalam's co-authors include Celia A. Schiffer, Akbar Ali, Tariq M. Rana, Hong Cao, G. Sudhakar Reddy, Saima Anjum, E.A. Nalivaika, Bruce Tidor, Anthony Forster and Virginia W. Cornish and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Virology.

In The Last Decade

M.N.L. Nalam

21 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.N.L. Nalam United States	21	689	658	577	222	208	21	1.3k
K. E. B. PARKES United Kingdom	15	640 0.9×	632 1.0×	513 0.9×	122 0.5×	400 1.9×	32	1.4k
Debananda Das United States	25	1.0k 1.5×	489 0.7×	920 1.6×	116 0.5×	263 1.3×	45	1.7k
M. Prabu-Jeyabalan United States	18	1.3k 1.9×	631 1.0×	1.2k 2.1×	163 0.7×	188 0.9×	19	1.7k
Rhonda B. Levin United States	9	527 0.8×	428 0.7×	405 0.7×	159 0.7×	425 2.0×	9	1.1k
Johnson Agniswamy United States	24	745 1.1×	446 0.7×	601 1.0×	85 0.4×	304 1.5×	55	1.3k
Marlene M. Rayner United States	14	597 0.9×	590 0.9×	533 0.9×	214 1.0×	527 2.5×	19	1.3k
Norman E. Wideburg United States	13	888 1.3×	613 0.9×	710 1.2×	123 0.6×	603 2.9×	29	1.5k
Linda Selk United States	7	935 1.4×	933 1.4×	812 1.4×	123 0.6×	298 1.4×	8	1.7k
E.A. Nalivaika United States	24	1.4k 2.1×	911 1.4×	1.3k 2.2×	258 1.2×	199 1.0×	39	2.1k
William E. Kohlbrenner United States	19	924 1.3×	774 1.2×	695 1.2×	140 0.6×	521 2.5×	34	1.9k

Countries citing papers authored by M.N.L. Nalam

Since Specialization

Citations

This map shows the geographic impact of M.N.L. Nalam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.N.L. Nalam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.N.L. Nalam more than expected).

Fields of papers citing papers by M.N.L. Nalam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.N.L. Nalam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.N.L. Nalam. The network helps show where M.N.L. Nalam may publish in the future.

Co-authorship network of co-authors of M.N.L. Nalam

This figure shows the co-authorship network connecting the top 25 collaborators of M.N.L. Nalam. A scholar is included among the top collaborators of M.N.L. Nalam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.N.L. Nalam. M.N.L. Nalam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nalivaika, E.A., M.N.L. Nalam, Kristina Prachanronarong, et al.. (2014). Drug Resistance Conferred by Mutations Outside the Active Site through Alterations in the Dynamic and Structural Ensemble of HIV-1 Protease. Journal of the American Chemical Society. 136(34). 11956–11963. 73 indexed citations

Nalam, M.N.L., Akbar Ali, G. Sudhakar Reddy, et al.. (2013). Substrate Envelope-Designed Potent HIV-1 Protease Inhibitors to Avoid Drug Resistance. Chemistry & Biology. 20(9). 1116–1124. 50 indexed citations

Shen, Yang, Michael D. Altman, Akbar Ali, et al.. (2013). Testing the Substrate-Envelope Hypothesis with Designed Pairs of Compounds. ACS Chemical Biology. 8(11). 2433–2441. 27 indexed citations

King, Bracken M., M.N.L. Nalam, Hong Cao, et al.. (2013). Efficient Computation of Small-Molecule Configurational Binding Entropy and Free Energy Changes by Ensemble Enumeration. Journal of Chemical Theory and Computation. 9(11). 5098–5115. 21 indexed citations

King, Nancy M. P., M. Prabu-Jeyabalan, R.M. Bandaranayake, et al.. (2012). Extreme Entropy–Enthalpy Compensation in a Drug-Resistant Variant of HIV-1 Protease. ACS Chemical Biology. 7(9). 1536–1546. 72 indexed citations

Parai, Maloy Kumar, David J. Huggins, Hong Cao, et al.. (2012). Design, Synthesis, and Biological and Structural Evaluations of Novel HIV-1 Protease Inhibitors To Combat Drug Resistance. Journal of Medicinal Chemistry. 55(14). 6328–6341. 40 indexed citations

Mittal, Seema, Yufeng Cai, M.N.L. Nalam, Daniel N. Bolon, & Celia A. Schiffer. (2012). Hydrophobic Core Flexibility Modulates Enzyme Activity in HIV-1 Protease. Journal of the American Chemical Society. 134(9). 4163–4168. 59 indexed citations

Dierynck, Inge, Herwig Van Marck, Marcia Van Ginderen, et al.. (2011). TMC310911, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, Shows In Vitro an Improved Resistance Profile and Higher Genetic Barrier to Resistance Compared with Current Protease Inhibitors. Antimicrobial Agents and Chemotherapy. 55(12). 5723–5731. 28 indexed citations

Shandilya, Shivender M.D., M.N.L. Nalam, E.A. Nalivaika, et al.. (2010). Crystal Structure of the APOBEC3G Catalytic Domain Reveals Potential Oligomerization Interfaces. Structure. 18(1). 28–38. 102 indexed citations

10.

Ali, Akbar, R.M. Bandaranayake, Yufeng Cai, et al.. (2010). Molecular Basis for Drug Resistance in HIV-1 Protease. Viruses. 2(11). 2509–2535. 113 indexed citations

11.

Ali, Akbar, G. Sudhakar Reddy, M.N.L. Nalam, et al.. (2010). Structure-Based Design, Synthesis, and Structure−Activity Relationship Studies of HIV-1 Protease Inhibitors Incorporating Phenyloxazolidinones. Journal of Medicinal Chemistry. 53(21). 7699–7708. 47 indexed citations

12.

Nalam, M.N.L., Akbar Ali, Michael D. Altman, et al.. (2010). Evaluating the Substrate-Envelope Hypothesis: Structural Analysis of Novel HIV-1 Protease Inhibitors Designed To Be Robust against Drug Resistance. Journal of Virology. 84(10). 5368–5378. 88 indexed citations

13.

Nalam, M.N.L. & Celia A. Schiffer. (2008). New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitors. Current Opinion in HIV and AIDS. 3(6). 642–646. 37 indexed citations

14.

Altman, Michael D., Akbar Ali, G. Sudhakar Reddy, et al.. (2008). HIV-1 Protease Inhibitors from Inverse Design in the Substrate Envelope Exhibit Subnanomolar Binding to Drug-Resistant Variants. Journal of the American Chemical Society. 130(19). 6099–6113. 87 indexed citations

15.

Reddy, G. Sudhakar, Akbar Ali, M.N.L. Nalam, et al.. (2007). Design of Mutation‐resistant HIV Protease Inhibitors with the Substrate Envelope Hypothesis. Chemical Biology & Drug Design. 69(5). 298–313. 43 indexed citations

16.

Reddy, G. Sudhakar, Akbar Ali, M.N.L. Nalam, et al.. (2007). Design and Synthesis of HIV-1 Protease Inhibitors Incorporating Oxazolidinones as P2/P2‘ Ligands in Pseudosymmetric Dipeptide Isosteres. Journal of Medicinal Chemistry. 50(18). 4316–4328. 57 indexed citations

17.

Nalam, M.N.L., Anik Peeters, Tim H. M. Jonckers, Inge Dierynck, & Celia A. Schiffer. (2007). Crystal Structure of Lysine Sulfonamide Inhibitor Reveals the Displacement of the Conserved Flap Water Molecule in Human Immunodeficiency Virus Type 1 Protease. Journal of Virology. 81(17). 9512–9518. 33 indexed citations

18.

Zhang, Baolin, et al.. (2007). Specificity of Translation for N-Alkyl Amino Acids. Journal of the American Chemical Society. 129(37). 11316–11317. 50 indexed citations

19.

Ali, Akbar, G. Sudhakar Reddy, Hong Cao, et al.. (2006). Discovery of HIV-1 Protease Inhibitors with Picomolar Affinities Incorporating N-Aryl-oxazolidinone-5-carboxamides as Novel P2 Ligands. Journal of Medicinal Chemistry. 49(25). 7342–7356. 90 indexed citations

20.

Forster, Anthony, Zhongping Tan, M.N.L. Nalam, et al.. (2003). Programming peptidomimetic syntheses by translating genetic codes designed de novo. Proceedings of the National Academy of Sciences. 100(11). 6353–6357. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact